Galápagos to acquire GSK research site

Wednesday 8 September 2010

Galápagos NV is set to acquire GlaxoSmithKline’s Zagreb, Croatia-based research site as well as provide research and development services to the UK multinational in a three-year fee-for-service contract.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium